-
Personalized.
-
Private.
-
Clinician‑guided.
-
Achieve sustainable weight loss with a modern, concierge approach that combines lifestyle coaching and advanced GLP‑1–based therapies—delivered with discretion and individualized care.
GLP-1 receptor agonists—such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) and Liraglutide—represent a significant advancement in the treatment of type 2 diabetes and obesity.
Originally developed to help manage blood sugar, these medications have also been shown to be highly effective for sustainable weight loss. When combined with personalized lifestyle changes—like healthy eating and regular physical activity—patients can experience meaningful improvements in both weight and metabolic health.
GLP-1 medications are generally well tolerated. Most side effects are mild, such as nausea or digestive upset, and can often be managed by adjusting the dose or timing.
Concierge Weight Loss with GLP‑1 Therapies
A Smarter Way to Lose Weight
Our practice offers comprehensive metabolic care designed around you. We start with a thorough intake, labs when appropriate, and ongoing check‑ins to help you reach real, lasting results.
GLP‑1 Therapies, Personalized: GLP‑1 receptor agonists can help reduce appetite, improve satiety, and support healthier metabolic signaling when paired with nutrition and movement strategies.
What you can expect?:
-
One‑on‑one concierge support
-
Individualized treatment plans
-
Ongoing monitoring and adjustments
-
Secure, private communication
Who this Is for?
-
Adults seeking medically guided weight loss
-
Individuals who value privacy and personalized care
-
Patients looking for an alternative to one‑size‑fits‑all programs
-
A medical screening is required. Not all patients are candidates for GLP‑1 therapies.
Safety & Transparency:
-
Care is provided by licensed clinicians
-
Potential benefits, risks, and alternatives are reviewed before starting
-
Ongoing monitoring for effectiveness and side effects
Important notes:
-
Compounded medications are prepared by accredited pharmacies when commercially available options are not suitable.
Our Concierge Difference:
-
Access: Direct communication with your clinician
-
Customization: Doses and plans tailored to your response
-
Continuity: Regular follow‑ups and progress tracking
-
Support: Nutrition, movement, and habit coaching integrated
Get Started!
-
Take the first step toward a healthier weight with care that fits your life.
-
Schedule a private consultation to see if our concierge GLP‑1 program is right for you.
Other GLP-1 Options (Beyond Injections)
Not everyone prefers injectable medications. Depending on your health history, goals, and eligibility, oral GLP-1 medications or other prescription weight management therapies may be appropriate alternatives.
We offer personalized evaluations to determine which option best fits your lifestyle, medical needs, and long-term goals. Your treatment plan may include:
-
Oral GLP-1 medications (when clinically appropriate)
-
Non-GLP-1 prescription weight loss medications
-
Lifestyle and nutrition counseling
-
Ongoing medical monitoring and follow-up
-
Personalized treatment adjustments to optimize results
Our goal is to provide safe, evidence-based weight management solutions tailored to each patient—whether that includes injectable therapy or an effective alternative.
Schedule a consultation today to discuss the treatment option that's right for you.
Tirzepatide Sublinguals
We now offer tirzepatide in carefully compounded, sublingual doses for select patients as part of a clinician‑directed plan.
NEW Tirzepatide LPT as a chewable scored tablet!
Utilizing an oral LPT delivery platform. Published literature on oral liposomal delivery suggests this approach may help support absorption of peptide-based compounds in the GI environment.
Why patients choose this option?:
-
Customized dosing based on tolerance and goals
-
Discreet administration
-
Close medical supervision
Treatment options and dosing are determined after a medical evaluation to ensure safety and appropriateness.
What's on the Horizon: Retatrutide
Exciting advances in obesity medicine continue to emerge, with Retatrutide being one of the most promising next-generation therapies currently under investigation. Unlike today's GLP-1 medications, Retatrutide is designed to activate three metabolic pathways (GLP-1, GIP, and glucagon receptors), which may provide greater improvements in weight loss and overall metabolic health.
In clinical studies, participants experienced substantial weight loss, along with improvements in blood sugar control, waist circumference, liver fat, and other cardiometabolic risk factors. By targeting multiple pathways involved in appetite regulation, energy expenditure, and metabolism, Retatrutide has the potential to help patients achieve results beyond those seen with current GLP-1 therapies.
While Retatrutide is not yet FDA-approved and is not currently available for routine clinical use, it represents an exciting step forward in the future of medical weight management. As new therapies become available and receive regulatory approval, our practice remains committed to offering evidence-based, cutting-edge treatment options to help patients achieve their long-term health goals.